REGISTER
What does it take to build a crazy idea into a burgeoning biotech? Can CRISPR become an accessible technology? Is Alzheimer's actually caused by a virus?
Join STAT reporters as they tackle some of the biggest questions in medicine with industry leading speakers including:
- Amy Abernethy, M.D, Ph.D., president of product development and chief medical officer, Verily
- Vineeta Agarwala, M.D., Ph.D., general partner, Andreessen Horowitz
- Alberto Ascherio, M.D., Dr.PH, professor of epidemiology and nutrition, Harvard TH Chan School of Public Health
- Jennifer Doudna, Ph.D., Nobel Laureate, co-inventor of CRISPR Technology; president, Innovative Genomics Institute
- Stephen Gillett, chief executive officer, Verily
- Vinod Khosla, founder, Khosla Ventures
- Priti Krishtel, J.D., co-founder and co-executive director, Initiative for Medicines, Access & Knowledge (I-MAK); 2022 MacArthur Fellow
- Daniel O'Day, chairman of the board of directors and chief executive officer, Gilead Sciences
- Emily Whitehead, co-founder, the Emily Whitehead Foundation
LEARN MORE

No comments